rs10256914

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_001753.5(CAV1):​c.195+8968T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.217 in 152,152 control chromosomes in the GnomAD database, including 3,901 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 3901 hom., cov: 32)

Consequence

CAV1
NM_001753.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.28

Publications

17 publications found
Variant links:
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pulmonary hypertension, primary, 3
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital generalized lipodystrophy type 3
    Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Berardinelli-Seip congenital lipodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.25 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAV1NM_001753.5 linkc.195+8968T>C intron_variant Intron 2 of 2 ENST00000341049.7 NP_001744.2 Q03135-1Q2TNI1Q59E85
CAV1NM_001172895.1 linkc.102+8968T>C intron_variant Intron 2 of 2 NP_001166366.1 A0A024R757Q2TNI1Q59E85
CAV1NM_001172896.2 linkc.102+8968T>C intron_variant Intron 1 of 1 NP_001166367.1 A0A024R757Q2TNI1Q7Z4F3Q59E85
CAV1NM_001172897.2 linkc.102+8968T>C intron_variant Intron 2 of 2 NP_001166368.1 A0A024R757Q2TNI1A9XTE5Q59E85

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAV1ENST00000341049.7 linkc.195+8968T>C intron_variant Intron 2 of 2 1 NM_001753.5 ENSP00000339191.2 Q03135-1

Frequencies

GnomAD3 genomes
AF:
0.217
AC:
32963
AN:
152034
Hom.:
3904
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.201
Gnomad AMI
AF:
0.317
Gnomad AMR
AF:
0.190
Gnomad ASJ
AF:
0.349
Gnomad EAS
AF:
0.0110
Gnomad SAS
AF:
0.202
Gnomad FIN
AF:
0.130
Gnomad MID
AF:
0.307
Gnomad NFE
AF:
0.254
Gnomad OTH
AF:
0.241
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.217
AC:
32961
AN:
152152
Hom.:
3901
Cov.:
32
AF XY:
0.209
AC XY:
15516
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.200
AC:
8315
AN:
41484
American (AMR)
AF:
0.190
AC:
2898
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.349
AC:
1211
AN:
3472
East Asian (EAS)
AF:
0.0110
AC:
57
AN:
5184
South Asian (SAS)
AF:
0.202
AC:
973
AN:
4812
European-Finnish (FIN)
AF:
0.130
AC:
1377
AN:
10586
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.254
AC:
17251
AN:
68008
Other (OTH)
AF:
0.238
AC:
503
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1321
2643
3964
5286
6607
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.249
Hom.:
19636
Bravo
AF:
0.222
Asia WGS
AF:
0.0950
AC:
333
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
18
DANN
Benign
0.81
PhyloP100
1.3
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10256914; hg19: chr7-116175711; API